论文部分内容阅读
目的:探讨阿仑膦酸钠对老年女性骨质疏松症患者的临床治疗效果。方法:选取我院2014年12月-2015年12月收治的患有骨质疏松症的80例老年女性患者,对其进行随机分组,给予对照组患者钙尔奇D片治疗,观察组则是在对照组治疗基础上增加阿仑膦酸钠治疗,比较其临床效果。结果:观察组患者的L2~4骨密度为(0.902±0.081)g/cm~2,生活质量评分为(93.88±8.26)分,对照组患者的L2~4骨密度为(0.810±0.086)g/cm~2,生活质量评分为(72.58±8.73)分,差异明显(P<0.05),有统计学意义。结论:阿仑膦酸钠治疗老年女性骨质疏松效果明显,增加患者的骨密度,缓解患者的躯体疼痛,建议在临床上使用。
Objective: To investigate the clinical effect of alendronate on elderly female patients with osteoporosis. Methods: A total of 80 elderly women with osteoporosis who were admitted from December 2014 to December 2015 in our hospital were randomly divided into two groups: control group, In the control group based on the increase of alendronate sodium treatment, compared with its clinical effect. Results: The BMD of L2 ~ 4 in the observation group was (0.902 ± 0.081) g / cm ~ 2 and the quality of life score was (93.88 ± 8.26). The BMD of L2 ~ 4 in the control group was (0.810 ± 0.086) g / cm ~ 2, quality of life score was (72.58 ± 8.73) points, the difference was significant (P <0.05), with statistical significance. Conclusion: Alendronate is effective in treating osteoporosis in elderly women, increasing bone mineral density and alleviating physical pain in the elderly. It is recommended to be used clinically.